Crescent Biopharma, Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $195 M for Crescent Biopharma, Inc., 462 times as much (market caps of Jan 5, 2024 for Crescent Biopharma, Inc. and Oct 30, 2026 for Moderna, Inc.). Crescent Biopharma, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B against $11 M for Crescent Biopharma, Inc., both in the year to December 2025.
- Both made a net loss: $154 M for Crescent Biopharma, Inc. and $2.8 B for Moderna, Inc.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -1420.1% for Crescent Biopharma, Inc.
- Moderna, Inc. employs more people: 4,700 against 44 at Crescent Biopharma, Inc. Each employee brings in about $246,364 of revenue at Crescent Biopharma, Inc. and $413,617 at Moderna, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Crescent Biopharma, Inc. CBIO | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2003 | 2010 |
| Size | ||
| Market cap | $195 M* | $90.1 B |
| Revenue | $11 M | $1.9 B |
| Net income | $-154 M▲ best | $-2.8 B |
| Employees | 44 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | -164.2% | -28.9%▲ best |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | -668.4% | -106.2%▲ best |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Crescent Biopharma, Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $195 M for Crescent Biopharma, Inc., 462 times as much (market caps of Jan 5, 2024 for Crescent Biopharma, Inc. and Oct 30, 2026 for Moderna, Inc.). Crescent Biopharma, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Crescent Biopharma, Inc. or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B against $11 M for Crescent Biopharma, Inc., both in the year to December 2025. Both made a net loss: $154 M for Crescent Biopharma, Inc. and $2.8 B for Moderna, Inc.
Which is more profitable, Crescent Biopharma, Inc. or Moderna, Inc.?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -1420.1% for Crescent Biopharma, Inc.
Which has more employees, Crescent Biopharma, Inc. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 44 at Crescent Biopharma, Inc. Each employee brings in about $246,364 of revenue at Crescent Biopharma, Inc. and $413,617 at Moderna, Inc.
More about Crescent Biopharma, Inc.
- Crescent Biopharma, Inc.: company page
- Who owns Crescent Biopharma, Inc.?
- Crescent Biopharma, Inc. market cap history
- Crescent Biopharma, Inc. revenue by year
- How many employees does Crescent Biopharma, Inc. have?
- Is Crescent Biopharma, Inc. cheap or expensive?
- Crescent Biopharma, Inc. against its peers: ranks and percentiles
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.